← Back to Clinical Trials
Recruiting NCT05721976

NCT05721976 With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05721976
Status Recruiting
Phase —
Sponsor University of Miami Sylvester Comprehensive Cancer Center
Condition Cancer, Breast
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-02-22
Primary Completion 2026-12-31

Eligibility & Interventions

Sex Female only
Min Age 21 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
With Love, Grandma ("Con Cariño, Abuelita")

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-02-22 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess the feasibility, acceptability, and preliminary effects of a digital (web and mobile-phone-based) program to improve lifestyle behaviors (physical activity, dietary intake) among Hispanic female cancer survivors and adult daughters.

Eligibility Criteria

Cancer Survivor Inclusion Criteria: * Grandmother * Self-identifies as Hispanic * Diagnosis of breast cancer (stages I-III), endometrial or ovarian cancer (stages I-II) * Completed active treatment (i.e., surgery, chemotherapy, and/or radiation) * Body Mass Index (BMI) ≥ 25 (overweight range) * Engages in \<150 minutes/week of moderate physical activity * English or Spanish speaking * Owns a mobile device with internet access (e.g., smartphone, tablet) * Lives in South Florida Daughter of Cancer Survivor Inclusion Criteria: * Adult daughter of the identified cancer survivor (21 years of age or older) * Has at least 1 living child ages ≤16 years old * Body Mass Index (BMI) ≥ 25 (overweight range) OR engages in \<150 minutes/week of moderate physical activity * English or Spanish speaking * Owns a mobile device with internet access (e.g., smartphone, tablet) * Lives in South Florida Daughter of Cancer Survivor Exclusion Criteria: * Has been diagnosed with distant metastatic cancer * Has not completed active treatment (i.e., surgery, chemotherapy, and/or radiation) * Has uncontrolled schizophrenia or bipolar disorder * Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions,wheelchair bound). Cancer Survivor Exclusion Criteria: * Has uncontrolled schizophrenia or bipolar disorder * Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions, wheelchair bound)

Contact & Investigator

Central Contact

Vanina Pavia, MD

✉ vxp395@miami.edu

📞 305-243-0726

Principal Investigator

Sara M St. George, PhD

PRINCIPAL INVESTIGATOR

University of Miami

Frequently Asked Questions

Who can join the NCT05721976 clinical trial?

This trial is open to female participants only, aged 21 Years or older, studying Cancer, Breast. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05721976 currently recruiting?

Yes, NCT05721976 is actively recruiting participants. Contact the research team at vxp395@miami.edu for enrollment information.

Where is the NCT05721976 trial being conducted?

This trial is being conducted at Miami, United States.

Who is sponsoring the NCT05721976 clinical trial?

NCT05721976 is sponsored by University of Miami Sylvester Comprehensive Cancer Center. The principal investigator is Sara M St. George, PhD at University of Miami. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology